Key facts
- Istios Health’s last known valuation is $14.0M (Jun 2025).
- It has raised $9.0M; the latest was Seed Round ($6.0M) in Jun 2025.
- Notable investors include BIP Ventures, RVM Enterprises.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Istios Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Istios Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Istios Health
Operator of a technology-enabled healthcare network intended to unify specialty practices and close gaps in patient care while expanding access to clinical research. The company offers telehealth hospital coverage, integrated specialty practice connectivity, and a nationwide research site infrastructure, enabling hospitals and independent Infectious Disease, Nephrology, Endocrinology, and Rheumatology practices to improve care continuity and accelerate clinical trial participation.
- Sector
- Healthcare
- HQ
- Phoenix, AZ, United States
- Founded
- 2018
- Employees
- 45
- Website
- istioshealth.com/
- Ownership
- Privately Held (backing)
Istios Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Istios Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Istios Health in its N-PORT filings yet. We sweep new filings monthly.